paclitaxel and s 1743
paclitaxel has been researched along with s 1743 in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Abadie-Lacourtoisie, S; Capitain, O; Lortholary, A | 1 |
Bae, DS; Choi, CH; Choi, JJ; Hong, JE; Jeon, HK; Kim, BG; Kim, TJ; Lee, JW; Song, T | 1 |
Chen, Y; He, J; Li, ZL; Li, ZM; Pan, XH; Shi, XY; Xiao, L; Yan, SJ | 1 |
Bai, Z; Ding, N; Ge, J; Liu, X; Wang, L; Wang, Y; Wei, Q; Wu, N; Xu, S; Zhou, G | 1 |
Other Studies
4 other study(ies) available for paclitaxel and s 1743
Article | Year |
---|---|
[Cytolytic hepatitis and esomeprazole during chemotherapy].
Topics: Adult; Anti-Ulcer Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemical and Drug Induced Liver Injury; Esomeprazole; Esophagitis; Female; Humans; Paclitaxel; Trastuzumab | 2005 |
Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Synergism; Esomeprazole; Female; Gene Expression; Humans; Immunohistochemistry; Paclitaxel; Proton Pump Inhibitors; Proton Pumps; RNA Interference; RNA, Small Interfering; Uterine Cervical Neoplasms; Vacuolar Proton-Translocating ATPases | 2017 |
Proton pump inhibitors can reverse the YAP mediated paclitaxel resistance in epithelial ovarian cancer.
Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Drug Resistance, Neoplasm; Esomeprazole; Female; Humans; Ovarian Neoplasms; Paclitaxel; Proton Pump Inhibitors; Transcription Factors; Tumor Microenvironment; Vacuolar Proton-Translocating ATPases; YAP-Signaling Proteins | 2019 |
Esomeprazole overcomes paclitaxel-resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Proliferation; Drug Resistance, Neoplasm; Esomeprazole; Humans; Paclitaxel; Up-Regulation; Vacuolar Proton-Translocating ATPases | 2021 |